Drugs / GenSci142
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT07663838 | Jun 2026 → Jan 2027 expected | bacterial vaginosis | Changchun GeneScience Pharmaceutical Co., Ltd. | Not yet recruiting | No outcome recorded |
| Phase 1 | NCT07302035 | Dec 2025 → Sep 2026 overdue | bacterial vaginosis | Changchun GeneScience Pharmaceutical Co., Ltd. | Not yet recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | GenSci142 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07302035 ↗ |
| Route | Other | “Vaginal insert” NCT07302035 ↗ |